Foundation - Thursday 22 April, 2021
Jacques Gendreau passed away in December 2020. He was monitored at the Institute for atrial fibrillation and a leaky heart valve. In order to thank the Institute for the excellent care he received, he chose to include a donation to the Foundation in his will. A heartfelt gesture that allows the Foundation to save more sensitive hearts.
Foundation, in collaboration with Dr. Judith Brouillette, psychiatrist - Tuesday 12 January, 2021
Dr. Judith Brouillette, head of the psychiatry department at the Montreal Heart Institute, is doubling down to find ways to safeguard the mental health of health care professionals. Here’s an overview of her innovative research and impressive career.
Foundation - Monday 19 October, 2020
Humans spend about one-third of their lives asleep. Did you know that this activity can affect your cardiovascular health? In fact, many of our biological functions recover and regenerate during sleep. Here's how to improve the quality of your sleep.
Foundation - Friday 9 October, 2020
With support from the MHI Foundation’s donors, Dr. Jean-Claude Tardif was able to launch COLCOT-T2D, the second phase of the COLCOT study. The goal is to demonstrate that colchicine can also prevent cardiovascular diseases in diabetics.
Foundation - Thursday 8 October, 2020
Researchers at the Montreal Heart Institute launched a global study titled COLCOT (COLchicine Cardiovascular Outcomes Trial) in 2014. The goal was to determine whether colchicine, a widely available drug, could prevent the risk of heart attacks in patients who had already experienced this kind of event.
Foundation - Wednesday 7 October, 2020
Colchicine is an orally administered drug which has been garnering a lot of interest in the past few months. It has recently been the subject of scientific studies that have identified new indications. Let’s take a look at this readily available drug that represents a new hope for people with a variety of health conditions.